Strategic Partnerships Global Genes has a history of corporate-nonprofit collaborations (RARE-X, RSZ TNC, Boston Children’s Hospital, Admedicum) and recently expanded with Citizen Health. This indicates a receptive environment for contracted collaboration, data-sharing initiatives, and co-branded programs that can be explored for sponsorships, joint ventures, and technology-enabled advocacy platforms.

Technology Backbone The organization relies on a modern tech stack (HubSpot, Salesforce, WordPress, monday.com, New Relic) to manage CRM, marketing, and operations. This suggests sales opportunities around integrated marketing automation, donor/member lifecycle solutions, analytics dashboards, and custom integrations that enhance efficiency and impact reporting.

RARE-X Focus Global Genes merged with RARE-X and runs the RARE-X Vision Consortium, highlighting a strong demand for tools, infrastructure, and data platforms that accelerate rare disease research and patient advocacy. Potential sales avenues include data collaboration platforms, patient registries, and tools that enable patient-centric research workflows.

Funding Scale With revenue in the mid-range and a notable funding line, the organization is positioned for scalable program investments. This presents opportunities for grant management solutions, programmatic software, sponsorship packages, and professional services to optimize fundraising campaigns and impact measurement.

Leadership Visibility Leadership recognition (CEO honored as Fierce 50) and active engagement in high-profile events (Rare Drug Development Symposium) indicate a favorable network and influence within the rare disease ecosystem. This can be leveraged for executive-led strategic partnerships, keynote opportunities, and targeted outreach to peak-level collaborators and donors.